 |
 |

COMMENTS AND OPINIONS
The Steroid Controversy in Bacterial Keratitis
Nisha R. Acharya, MD, MS;
Muthiah Srinivasan, MD;
Jeena Mascarenhas, MD;
Meenakshi Ravindran, MD;
Revathi Rajaraman, MD;
Michael Zegans, MD;
Stephen McLeod, MD;
Thomas M. Lietman, MD
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
The January 2009 Controversies series of articles highlights a major debate.1-2 Some corneal specialists use adjunctive corticosteroids to reduce scarring in bacterial keratitis. Others fear that suppressing the immune system is the worst thing you can do. Hindman and Patel et al1 state that only a single, underpowered trial has addressed this and suggest that a large definitive trial is necessary to end the debate. By the time this Controversies series was published, there had actually been 2 published trials,3-4 and a third, large trial is well under way.
We recently published the results of a randomized trial of 42 patients that studied the effect of adjunctive topical steroids in bacterial keratitis.4 Although steroids affected neither acuity nor scar size, they did significantly . . . [Full Text of this Article] AUTHOR INFORMATION
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED ARTICLES
The Case Against the Use of Steroids in the Treatment of Bacterial Keratitis
Elisabeth J. Cohen
Arch Ophthalmol. 2009;127(1):103-104.
EXTRACT
| FULL TEXT
Rationale for Adjunctive Topical Corticosteroids in Bacterial Keratitis
Holly B. Hindman, Sheel B. Patel, and Albert S. Jun
Arch Ophthalmol. 2009;127(1):97-102.
EXTRACT
| FULL TEXT
|